ISIN: DE000UD137W6 SSPA product type:: Express Certificates (1260)
Bid
1.007,00
EUR
Volume:
10
| Type | Instrument |
| Underlying | GlaxoSmithKline / Merck & Co. / Novo Nordisk |
| WKN | UD137W |
| ISIN | DE000UD137W6 |
| Currency | EUR |
| Issue date | 31.01.2020 |
| Expiry | 31.01.2023 |
| Underlying price1) GlaxoSmithKline Merck & Co. Novo Nordisk | -- GBP 110,04 USD 893,80 DKK |
Important legal and regulatory information. The use and access of these web pages, or any other linked web sites provided by UBS AG and/or any subsidiary, affiliate or branch thereof (together, "UBS"), and any content herein, including posted documents, (collectively, these "Materials") are subject to this disclaimer and any other posted restrictions. The products and/or services described herein may not be eligible for sale in all jurisdictions or to certain categories of investors. You should contact your own broker if you wish to trade. In the event of any contradiction or inconsistency between this Disclaimer and the Terms of Use applicable to the UBS website (www.ubs.com), the terms set out in this Disclaimer shall prevail. Approved by UBS Europe SE, a subsidiary of UBS AG. Selected market data provided by Solvians. © Copyright by UBS AG, 1998 - 2022. The key symbol and UBS are among the registered and unregistered trademarks of UBS. Other marks may be trademarks of their respective owners. All rights reserved.
